Abstract

This study aimed to investigate the prevalence of depression, anxiety, and stress among in-patients diagnosed with various endocrine disorders. Quality of life (QoL) was also evaluated using the WHOQoL-BREF questionnaire. Material and Methods: The study included 110 patients. Participants were assessed for depression using the Hamilton Depression Rating Scale (HDRS), for anxiety using the Hamilton Anxiety Scale (HAM-A), and for stress using the Perceived Stress Scale (PSS). Results: The majority of patients had Type-2 Diabetes Mellitus (46.4%) or hypothyroidism (33.6%). The study showed that 22% of endocrine patients exhibited signs of depression, with the highest depression rate found among PCOD patients (58.3%). Anxiety was prevalent across all endocrine disorders, with the most severe cases found among hyperthyroid patients (66%). Regarding stress levels, most patients with Type-2 Diabetes and hypothyroidism reported moderate stress (70% and 86% respectively), while PCOD patients reported moderate (66%) and high stress (33.3%). Quality of life varied, with physical health ranging from 17.86 to 85.7 (mean 48.5), psychological health ranging from 20.83 to 70.8 (mean 50.9), social health ranging from 8.33 to 91.6 (mean 56.4), and environmental health ranging from 15.63 to 87.5 (mean 56.5). Conclusion: In conclusion, endocrine disorders can have far-reaching effects on mental health, causing depression, anxiety, and stress. Understanding these connections and integrating mental health care into treatment plans is crucial to improving patient outcomes.

Description